Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 13Breast Neoplasms 9Prostatic Neoplasms 4Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain, Postoperative 3Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Lymphoma 2Hemorrhage 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Peritoneal Neoplasms 1Peripheral Nervous System Diseases 1Pancreatic Cyst 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neurotoxicity Syndromes 1Myofibroma 1Multiple Myeloma 1Metabolic Diseases 1Melanoma 1

Interventions

Paclitaxel 30Carboplatin 24Cisplatin 11Topotecan 8liposomal doxorubicin 6Hyperthermic Intraperitoneal Chemotherapy 6mirvetuximab soravtansine 5Cyclophosphamide 5Drug Therapy 4Chemotherapy, Adjuvant 4Bevacizumab 4rucaparib 3Peripheral Blood Stem Cell Transplantation 3Neoadjuvant Therapy 3Doxorubicin 3Docetaxel 3CP protocol 3olaparib 2liposomal amphotericin B 2Surgical Procedures, Operative 2Letrozole 2Gemcitabine 2trebananib 1trastuzumab deruxtecan 1phenoxodiol 1pembrolizumab 1oregovomab 1niraparib 1fluzoparib 1epothilone B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Ovarian Epithelial × Saline Solution × Clear all
NCT05116189 2026-03-09

KEYNOTE-B96

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
643 enrolled 17 charts 1 FDA
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡